SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:

[_]  Preliminary Proxy Statement

[_]  Confidential, for Use of the Commission Only (as permitted by
     Rule 14a-6(e)(2))

[_]  Definitive Proxy Statement

[X]  Definitive Additional Materials

[_]  Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12

                         INSIGHT HEALTH SERVICES CORP.
--------------------------------------------------------------------------------
               (Name of Registrant as Specified In Its Charter)


--------------------------------------------------------------------------------
   (Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of Filing Fee (Check the appropriate box):

[X]  No fee required.

[_]  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

     (1) Title of each class of securities to which transaction applies:


     (2) Aggregate number of securities to which transaction applies:


     (3) Per unit price or other underlying value of transaction computed
         pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
         the filing fee is calculated and state how it was determined):


     (4) Proposed maximum aggregate value of transaction:


     (5) Total fee paid:


[_]  Fee paid previously with preliminary materials.

[_]  Check box if any part of the fee is offset as provided by Exchange
     Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
     was paid previously. Identify the previous filing by registration statement
     number, or the Form or Schedule and the date of its filing.

     (1) Amount Previously Paid:


     (2) Form, Schedule or Registration Statement No.:


     (3) Filing Party:


     (4) Date Filed:



[LOGO OF INSIGHT]



                            N e w s  R e l e a s e

                                                                       Contacts:
                                                                     At InSight:
                                                             Steven T. Plochocki
                                                                 President & CEO
                                                                    949-476-0733

                                                                 Thomas V. Croal
                                                  Executive Vice President & CFO
                                                                    949-476-0733



                    INSIGHT HEALTH SERVICES CORP. ANNOUNCES
          BRIDGE FINANCING COMMITMENT RELATING TO THE PROPOSED MERGER

     NEWPORT BEACH, Calif.........October 9, 2001.........InSight Health
Services Corp. ("InSight") (NASDAQ: IHSC) today announced that Banc of America
and its affiliates have committed, subject to certain terms and conditions, to
provide $200 million in senior subordinated debt financing which is required to
complete the previously announced proposed merger.  In addition, the InSight
board of directors has agreed to extend by one day the date by which any party
may terminate the agreement and plan of merger, if the merger is not completed,
to October 18, 2001.

     As disclosed previously, the special meeting of InSight stockholders will
take place on October 17, 2001, at 8:00 a.m., pacific standard time, at the
Sutton Place Hotel, 4500 MacArthur Boulevard, Newport Beach, California, for the
purpose of adopting the agreement and plan of merger.

     Newport Beach, Calif.-based InSight Health Services Corp. provides
diagnostic imaging and information, treatment and related management services.
It serves managed care entities, hospitals and other contractual customers in 28
U.S. states.  Visit InSight's web site at www.insighthealthcorp.com.
                                          -------------------------

The matters set forth in this release are forward-looking statements that are
dependent on certain risks and uncertainties, including such factors as
availability of financing; limitations and delays in reimbursement by third
party payors; contract renewals and financial stability of customers; the
potential for rapid and significant changes in technology and the effect on the
Company's operations; operating, legal, governmental and regulatory risks;
adverse utilization trends for certain diagnostic imaging procedures; economic,
political and competitive forces affecting the Company's business; the Company's
ability to successfully integrate acquisitions, and other risk factors detailed
in the Company's SEC filings.